Skip to main content
. 2002 Dec 26;2:37. doi: 10.1186/1471-2407-2-37

Table 7.

Estimated global and regional number of cancer deaths and age-standardised mortality rate by site, females, 2000

WHO sub region

World AFRO AMRO EMRO EURO SEARO WPRO






Site D E A B D B D A B1 B2 C B D A B1 B2 B3
Number of deaths (000s)
Mouth and oropharynx cancers 97.2 5.3 7.1 3.3 2.7 0.5 1.1 0.6 5.7 1.5 0.3 2.9 5.5 42.7 1.7 13.6 2.6 0.2
Oesophagus cancer 157.6 4.0 6.8 3.7 3.8 0.3 1.5 0.5 7.8 1.0 1.3 3.5 2.3 33.6 2.0 83.6 2.0 0.0
Stomach cancer 324.2 8.9 7.2 7.0 16.5 7.1 3.7 1.6 27.9 8.6 2.2 30.6 5.5 16.1 19.0 157.7 4.6 0.1
Colon and rectum cancers 295.5 5.6 5.3 37.2 16.1 2.1 2.2 1.7 69.7 11.8 1.1 33.61 3.6 14.01 9.4 59.72 2.2 0.1
Liver cancer 191.0 11.0 9.8 5.3 9.1 3.2 1.2 1.1 13.3 3.8 0.5 5.6 10.6 10.4 10.5 93.5 2.2 0.2
Pancreas cancer 105.6 1.5 2.5 16.9 8.7 1.2 0.7 0.6 26.9 4.6 0.7 9.8 3.3 5.2 9.4 13.0 0.5 0.0
Trachea, bronchus, lung cancers 323.8 2.9 4.5 70.5 14.9 0.9 2.5 2.3 49.2 9.8 1.1 16.2 7.5 23.2 16.9 97.6 3.7 0.2
Melanoma of the skin 30.1 2.4 3.0 4.3 2.7 0.6 0.2 0.1 7.2 1.9 0.2 3.0 1.0 1.0 1.1 1.2 0.1 0.0
Breast cancer 466.3 18.6 23.0 53.3 30.7 4.0 5.1 7.0 91.8 18.5 2.5 39.4 29.0 67.0 12.4 57.5 6.3 0.2
Cervix uteri cancer 259.6 24.1 36.8 5.3 19.3 4.6 3.5 2.6 8.3 6.3 1.0 11.7 15.4 86.2 2.6 26.1 5.4 0.3
Corpus uteri cancer 72.9 1.4 1.7 8.2 10.4 3.5 0.4 0.3 16.0 4.3 0.8 11.0 4.0 3.2 3.3 4.1 0.2 0.0
Ovary cancer 128.6 3.9 6.7 15.5 7.0 1.1 0.9 0.9 25.7 5.7 0.6 12.9 8.7 18.5 4.9 13.8 1.6 0.1
Prostate cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Bladder cancer 53.5 2.3 2.0 4.9 2.1 0.3 0.5 2.0 10.5 1.7 0.2 2.8 1.4 14.2 1.9 6.3 0.6 0.0
Lymphomas, multiple myeloma 163.7 6.6 5.2 21.7 8.0 1.6 2.8 2.4 27.4 4.3 0.5 4.8 6.1 54.8 6.2 9.4 1.8 0.1
Leukaemia 114.7 4.4 4.9 12.0 8.4 1.9 1.7 2.5 17.2 3.8 0.7 7.2 7.2 14.7 3.6 23.1 1.4 0.1
Other malignant neoplasms 344.5 29.4 14.8 32.0 33.2 6.9 5.1 5.1 63.0 16.4 2.4 29.6 15.5 19.9 18.3 49.5 3.4 0.2

Age-standardized mortality rate per 100,000
Mouth and oropharynx cancers 3.2 6.6 8.8 1.3 1.5 2.2 2.5 1.3 1.4 1.4 1.4 1.3 3.7 9.9 1.0 2.0 4.9 10.8
Oesophagus cancer 5.3 5.0 8.8 1.3 2.1 1.4 3.8 1.1 1.6 0.9 6.1 1.4 1.6 7.7 1.2 12.7 3.8 1.7
Stomach cancer 10.8 11.3 9.2 2.5 9.1 32.2 9.0 3.6 5.8 7.9 10.6 13.0 3.7 3.8 11.5 24.1 8.7 2.6
Colon and rectum cancers 9.9 7.0 7.0 13.0 8.9 9.4 5.6 3.7 14.4 10.7 5.3 13.9 9.3 3.3 11.6 9.1 4.2 2.6
Liver cancer 6.4 12.4 11.5 2.0 5.0 13.9 3.0 2.4 2.9 3.4 2.2 2.4 7.1 2.1 6.2 13.9 3.9 6.9
Pancreas cancer 3.5 1.7 3.4 6.1 4.8 5.6 1.7 1.5 5.7 4.1 3.4 4.1 2.3 1.2 5.5 2.0 0.9 0.3
Trachea, bronchus, lung cancers 10.8 3.2 5.3 27.4 8.0 4.0 6.0 5.2 11.6 9.0 5.1 6.9 4.9 4.9 10.1 14.5 6.8 7.7
Melanoma of the skin 1.0 3.1 4.1 1.7 1.5 2.6 0.4 0.3 1.7 1.8 1.0 1.5 0.7 0.2 0.7 0.2 0.1 1.5
Breast cancer 15.6 21.4 27.7 21.1 16.0 16.1 12.2 14.4 22.8 17.4 12.0 18.7 17.6 14.5 9.4 8.1 11.3 12.0
Cervix uteri cancer 8.7 27.4 43.8 2.4 9.8 18.7 8.7 5.5 2.3 6.1 4.7 5.9 9.3 18.0 2.0 3.9 9.7 15.5
Corpus uteri cancer 2.4 1.9 2.3 3.1 5.5 1.5 1.0 0.8 3.5 3.9 3.8 4.7 2.6 0.8 2.1 0.6 0.4 1.2
Ovary cancer 4.3 4.3 8.1 6.1 3.7 4.4 2.2 1.8 6.3 5.3 3.0 6.0 5.3 4.1 3.5 2.0 2.9 3.2
Prostate cancer 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Bladder cancer 1.8 2.9 2.6 1.6 1.2 1.2 1.4 4.6 2.0 1.5 0.9 1.1 1.1 3.1 1.0 1.0 1.1 0.2
Lymphomas, multiple myeloma 5.5 6.7 5.6 7.9 4.2 6.5 6.3 4.8 6.1 4.1 2.4 2.3 3.9 11.7 3.8 1.4 3.0 3.1
Leukaemia 3.8 4.7 5.1 4.6 4.1 6.5 3.1 4.3 4.1 3.8 2.8 3.8 4.1 2.6 2.7 3.6 2.1 2.2
Other malignant neoplasms 11.5 34.3 18.0 12.5 17.6 28.6 12.5 10.9 14.6 15.3 11.0 14.1 10.1 4.9 11.0 7.7 6.3 8.2
HHS Vulnerability Disclosure